A phase 1, double-blind, placebo-controlled, randomized, single ascending dose and multiple ascending dose study to assess the safety, tolerability, and pharmacokinetics of GHF-201 in healthy adult volunteers

Status

Recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-519813-74-00

Acronym

CGH24001

Enrollment

Registered

2025-04-17

Start date

2025-06-27

Completion date

Unknown

Last updated

2025-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult polyglucosan body disease (APBD).

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026